| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8240056 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 8 Pages |
Abstract
Possession of certain TGFB1 genotypes is associated with the development of both erectile dysfunction and late rectal bleeding in patients treated with radiotherapy for prostate cancer. Therefore, identification of patients harboring these genotypes may represent a means to predict which men are most likely to suffer from poor quality-of-life outcomes after radiotherapy for prostate cancer.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Christopher A. M.D., Richard G. M.D., Jamie A. M.D., David P. Ph.D., Sheila B.A., Ryan J. M.D., Nelson N. M.D., Harry M.D., Barry S. Ph.D.,